Niagen Bioscience, Inc. — Director's Dealing 2023

Jun 13, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ChromaDex Corp. (CDXC)
CIK: 0001386570
Period of Report: 2023-06-12

Reporting Person: Jaksch Frank L Jr (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-06-12	Common Stock	P	7000	$1.69	Acquired	231339	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	2075052	Indirect

Footnotes

F1: Held by Black Sheep, FLP, a California limited partnership, of which the Reporting Person and Tricia A. Jaksch are the sole co-general partners and the Reporting Person, Tricia A. Jaksch and certain trusts for the benefit of the Reporting Person?s family are the sole limited partners.